Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glide Pharmaceutical Technologies Ltd.

www.glidepharma.com

Latest From Vir Biotechnology Inc.

Start-Up Quarterly Statistics: Early Funding Declined, But Deal Dollars Flowed

A review of biopharma startup dealmaking and financing activity from January through March 2017, based on data from Strategic Transactions, showed a 19% decline in startup financing compared with the fourth quarter of 2016, but big pharmas provided capital in the form of alliance fees.

StartUps and SMEs Financing

Venture Funding Deals: Takeda Ups Its Bet On Immuno-Oncology Play Maverick

Biscayne and Japanese CRO SNBL create spin-outs to advance programs; liver disease specialist Ascletis gains funds as it shifts away from HCV; Neon gets $100m to put into its cancer vaccines; and other highlights of recent VC funding.

StartUps and SMEs Financing

Biotech Execs Speak Out Against Trump’s Immigration Ban; Big Pharma Remains Mostly Silent

Letter initiated by six CEOs drew 'absolutely overwhelming' response as 163 leaders of primarily small biotech and venture capital firms signed on; tech firms join court fight.

Policy & Regulation

Biotech Execs Speak Out Against Trump’s Immigration Ban; Big Pharma Remains Mostly Silent

Letter initiated by six CEOs drew 'absolutely overwhelming' response as 163 leaders of primarily small biotech and venture capital firms signed on; tech firms join court fight.

BioPharmaceutical Policy
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Caretek Medical Ltd.
  • Glide Pharmaceutical Technologies Ltd.
  • Glide Pharma Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Glide Pharmaceutical Technologies Ltd.
  • Senior Management
  • James Otter, Interim CEO
    Imogen Collis, CSO
  • Contact Info
  • Glide Pharmaceutical Technologies Ltd.
    Phone: (44) 1235 577 120
    45B/C Western Ave.
    Milton Pk.
    Abingdon, OX14 4RU
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register